Mayne Pharma Group Limited (MAYNF) Financials

MAYNF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 627.7 million 357.9 million
Dec. 31, 2025 628.0 million 392.5 million
June 30, 2025 667.2 million 423.7 million
Dec. 31, 2024 702.6 million 425.4 million

MAYNF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 15.2 million ?
Dec. 31, 2025 -6.3 million ?
June 30, 2025 16.5 million 1.2 million
Dec. 31, 2024 -12.4 million 1.3 million

MAYNF Net Income

No data available :(

MAYNF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 56.8 million - 1.1 million
Dec. 31, 2025 45.0 million 1.4 million 1.4 million
June 30, 2025 66.0 million - 4.0 million
Dec. 31, 2024 77.6 million - 4.0 million

MAYNF Shares Outstanding

No data available :(

MAYNF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1.1 million 5.5 million 71.1 million -
Dec. 31, 2025 873976 8.4 million 81.7 million -
June 30, 2025 3.6 million 5.7 million 82.2 million 46.6 million
Dec. 31, 2024 4.3 million 6.7 million 78.5 million 41.0 million

MAYNF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 118.4 million 60.8 million
Dec. 31, 2025 141.6 million 70.3 million
June 30, 2025 128.3 million 51.7 million
Dec. 31, 2024 132.4 million 51.1 million

MAYNF

Price: $1.85

52 week price:
1.40
4.00

Earnings Per Share: 0.28 USD

P/E Ratio: 8.39

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - General

Market Capitalization: 166.6 million

Links: